Follow
Dr. Mateq Ali Alreshidi   الدكتور/ معتق بن علي الرشيدي
Dr. Mateq Ali Alreshidi الدكتور/ معتق بن علي الرشيدي
Assistant Professor, faculty of Medicine, Alrajhi University
Verified email at sr.edu.sa - Homepage
Title
Cited by
Cited by
Year
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
54342021
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...
The Lancet 396 (10249), 467-478, 2020
28242020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...
The Lancet 396 (10267), 1979-1993, 2020
17052020
Synthesis, characterization, applications, and challenges of iron oxide nanoparticles
A Ali, H Zafar, M Zia, I ul Haq, AR Phull, JS Ali, A Hussain
Nanotechnology, science and applications, 49-67, 2016
15812016
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
13592021
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...
The Lancet 397 (10285), 1637-1645, 2021
4022021
Remittances, growth and poverty: New evidence from Asian countries
KS Imai, R Gaiha, A Ali, N Kaicker
Journal of Policy Modeling 36 (3), 524-538, 2014
3522014
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10274), 605, 2021
3212021
Effect of ZnO Nanoparticles on Brassica nigra Seedlings and Stem Explants: Growth Dynamics and Antioxidative Response
H Zafar, A Ali, JS Ali, IU Haq, M Zia
Frontiers in plant science 7, 535, 2016
2792016
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
A Flaxman, NG Marchevsky, D Jenkin, J Aboagye, PK Aley, B Angus, ...
The Lancet 398 (10304), 981-990, 2021
2742021
Antioxidant, cytotoxic and antimicrobial activities of green synthesized silver nanoparticles from crude extract of Bergenia ciliata
AR Phull, Q Abbas, A Ali, H Raza, M Zia, I Haq
Future Journal of Pharmaceutical Sciences 2 (1), 31-36, 2016
2692016
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ...
The Lancet 400 (10349), 359-368, 2022
2332022
Prevalence of Adhesion and Regulation of Biofilm‐Related Genes in Different Clones of Staphylococcus aureus
SS Atshan, M Nor Shamsudin, Z Sekawi, LTT Lung, RA Hamat, ...
BioMed Research International 2012 (1), 976972, 2012
2092012
Discovery, development, and patent trends on molnupiravir: a prospective oral treatment for COVID-19
M Imran, M Kumar Arora, SMB Asdaq, SA Khan, SI Alaqel, ...
Molecules 26 (19), 5795, 2021
1912021
The impact of macroeconomic instability on social progress: an empirical analysis of Pakistan
A ALI
National College of Business Administration & Economics Lahore, 2015
1782015
Elemental zinc to zinc nanoparticles: Is ZnO NPs crucial for life? Synthesis, toxicological, and environmental concerns
A Ali, AR Phull, M Zia
Nanotechnology Reviews 7 (5), 413-441, 2018
1762018
Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy
G Levent, A Ali, A Ahmet, EC Polat, Ç Aytaç, E Ayºe, S Ahmet
Journal of Translational Medicine 4, 1-6, 2006
1742006
Breast-cancer screening with trained volunteers in a rural area of Sudan: a pilot study
DO Abuidris, A Elsheikh, M Ali, H Musa, E Elgaili, AO Ahmed, I Sulieman, ...
The lancet oncology 14 (4), 363-370, 2013
1462013
Quantitative PCR analysis of genes expressed during biofilm development of methicillin resistant Staphylococcus aureus (MRSA)
SS Atshan, MN Shamsudin, A Karunanidhi, A van Belkum, LTT Lung, ...
Infection, genetics and evolution 18, 106-112, 2013
1442013
Watching rocks change-mechanical earth modeling
T Brown, R Delgado, D Spooner, T Stouffer, AHA Ali, D Lee, D Plumb, ...
Oilfield Review 15 (2), 22-39, 2003
1392003
The system can't perform the operation now. Try again later.
Articles 1–20